CASR and malignant colon neoplasm: Colon cancer cells transfected with CaSR express lower levels of thymidylate synthase (TS) (Liu et al., 2010), an enzyme involved in de novo DNA synthesis which is the target of the main colon cancer drug 5-fluoro uracil (5-FU) (Chu et al., 2003).